Post-exercise Therapeutic Modalities on Functional Performance, Muscle Damage and Oxidative Stress of CrossFit® Athletes

NCT ID: NCT06628609

Last Updated: 2024-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-11

Study Completion Date

2024-11-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Crossfit® is a training modality that consists in functional movements, constantly varied and executed at high intensity. Both training sessions and competitions involve physically demanding activities, which in addition to being performed at very high intensity also involves the aerobic metabolism pathway. These characteristics led to very high metabolic and muscular stress, as well as decrease in physical performance immediately after competitions and training sessions. The cumulative effects of the metabolic and muscular stress can be a precursor of injuries. Studies using different therapeutic modalities aiming to improve post-exercise recovery are needed in order to tackle this issue.

Oxidative stress induced by exercise has been a research field in constant growth, due to its relationship with the processes of fatigue, decreased production of muscle strength, and its ability to cause damage to the cell.

To the date there are no studies comparing the effects of different therapeutic modalities applied after an exercise session on functional performance, muscle damage, and oxidative stress in an exercise modality such as Crossfit®.

Therefore, the aim of this project is to assess and compare the effects of different therapeutic modalities on functional performance, muscle damage, and oxidative stress of Crossfit® athletes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized, crossover, controlled trial will be carried out.

All volunteers will be allocated to four interventions, and the order of the interventions will be randomized.

The outcomes will be assessed at baseline (prior to the Workout of the Day - WOD), and in different timepoints after the WOD.

The WOD will be consisted in finishing as quickly as possible a sequence of three exercises (Calories in Assault AirBike®, Hang Squat Clean and Box Jump Over), in a well-known series model for the athletes, without rest.

The investigators will analyze functional performance, biochemical markers of muscle damage and oxidative stress, the ratings of perceived exertion, and the volunteers satisfaction with the interventions.

All data will be analyzed both in their absolute values and in relation to their percentage variation from the values obtained in the pre-WOD (baseline) assessments.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Exercise Recovery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Passive recovery for 30 minutes

Group Type OTHER

Passive recovery

Intervention Type OTHER

Volunteers laid in supine position resting for 30 minutes.

PBMT-sMF

Photobiomodulation therapy combined with static magnetic field, with a total treatment duration lasting for around 30 minutes.

Group Type EXPERIMENTAL

PBMT-sMF

Intervention Type DEVICE

PBMT-sMF applied in the lower limbs with different doses per muscle group.

Shock wave

Shock wave therapy applied for 30 minutes.

Group Type ACTIVE_COMPARATOR

Shock wave

Intervention Type DEVICE

Shock wave therapy applied in the lower limbs for 30 minutes.

Pneumatic compression

Pneumatic compression applied for 30 minutes.

Group Type ACTIVE_COMPARATOR

Pneumatic compression

Intervention Type DEVICE

Pneumatic compression applied in the lower limbs for 30 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Passive recovery

Volunteers laid in supine position resting for 30 minutes.

Intervention Type OTHER

PBMT-sMF

PBMT-sMF applied in the lower limbs with different doses per muscle group.

Intervention Type DEVICE

Shock wave

Shock wave therapy applied in the lower limbs for 30 minutes.

Intervention Type DEVICE

Pneumatic compression

Pneumatic compression applied in the lower limbs for 30 minutes.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Inclusion Criteria: - Crossfit® amateur male athletes; - Do not present a history of musculoskeletal injury in the regions of the hips, knees and calves in the month preceding the study; - Are not using pharmacological agents; - Athletes should have been practicing the sport for at least 1 year; - Voluntarily commit to participate in all stages of the study.

Exclusion Criteria: - Present musculoskeletal or joint injuries during data collection; - Present history of musculoskeletal injury in the regions of the hips, knees and calves in the month preceding the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Nove de Julho

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ernesto Cesar Pinto Leal Junior

Full Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ernesto Cesar Pinto Leal Junior, Ph.D., M.Sc., PT.

Role: PRINCIPAL_INVESTIGATOR

Nove de Julho University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Laboratory of Phototherapy and Innovative Technologies in Health

São Paulo, São Paulo, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3.997.120

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RE and Probiotics in MAFLD/NAFLD
NCT06563921 NOT_YET_RECRUITING NA